These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2459898)

  • 1. Amylase activity and fast-migrating amylase isoenzymes in serum and cyst fluid from patients with ovarian neoplasms.
    Henriksen R; Brock A
    Acta Obstet Gynecol Scand; 1988; 67(1):65-70. PubMed ID: 2459898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialyl salivary-type amylase associated with ovarian cancer.
    Moriyama T
    Clin Chim Acta; 2008 May; 391(1-2):106-11. PubMed ID: 18294455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alterations in the activity of amylase and its salivary isoenzyme in the serum of patients with ovarian carcinoma, submitted to radiotherapy.
    Zakrzewska I; Pietryńczak M
    Rocz Akad Med Bialymst; 1997; 42(1):229-35. PubMed ID: 9581485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serous ovarian neoplastic amylase (SONA): a potentially useful marker for serous ovarian tumors.
    Van Kley H; Cramer S; Bruns DE
    Cancer; 1981 Sep; 48(6):1444-9. PubMed ID: 6168366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An amylase-producing serous cystadenocarcinoma of the ovary.
    Hodes ME; Sisk CJ; Karn RC; Ehrlich CE; Lehrner LM; Roth LM; Morley DJ; Merritt AD
    Oncology; 1985; 42(4):242-7. PubMed ID: 2409494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperamylasemia and ovarian carcinoma.
    Sandiford JA; Chiknas SG
    Clin Chem; 1979 Jun; 25(6):948-50. PubMed ID: 445830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved DEAE-Sephadex column chromatography in measuring amylase in serous ovarian neoplasms, and results for 13 cases.
    Zakowski JJ; Bruns DE
    Clin Chem; 1982 Oct; 28(10):2095-8. PubMed ID: 6181909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylase in fallopian tube and serous ovarian neoplasms: immunohistochemical localization.
    Bruns DE; Mills SE; Savory J
    Arch Pathol Lab Med; 1982 Jan; 106(1):17-20. PubMed ID: 6172088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylase elevation attributable to an ovarian neoplasm.
    Corlette MB; Dratch M; Sorger K
    Gastroenterology; 1978 May; 74(5 Pt 1):907-9. PubMed ID: 640346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of human alpha amylase isoenzymes.
    Zakowski JJ; Bruns DE
    Crit Rev Clin Lab Sci; 1985; 21(4):283-322. PubMed ID: 2578342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
    Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
    Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary.
    Hayakawa T; Kameya A; Mizuno R; Noda A; Kondo T; Hirabayashi N
    Cancer; 1984 Oct; 54(8):1662-5. PubMed ID: 6206939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report].
    Kawamurra S; Hiura M; Kaneko H; Yokoyama T; Tanaka M; Chiba T; Moriwaki S
    Gan No Rinsho; 1988 Apr; 34(4):497-504. PubMed ID: 2451762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of electrophoretic pattern of amylase isoenzymes to severity of pancreatic disease.
    Otsuki M; Yuu H; Maeda M; Yamasaki T; Okano K; Sakamoto C; Baba S
    Clin Chim Acta; 1977 Aug; 79(1):1-6. PubMed ID: 890943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary.
    Schlikker I; Nakad A; Gerbaux A; Azzouzi K; Kadou J; Lezaire P; Janssen A; Piessevaux H; Dive C
    Acta Clin Belg; 1989; 44(4):255-8. PubMed ID: 2482644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of amylase-producing ovarian tumor].
    Tanaka Y; Ueda G; Tanizawa O; Miyake H; Kohno M; Nishiyama S; Inoue H; Ikeuchi H; Sekigawa S; Matsunaga S
    Gan No Rinsho; 1986 Jan; 32(1):111-6. PubMed ID: 2419596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoplasm of the ovary as a cause of hyperamylasemia].
    Pose Reino A; Suárez Dono J; Codesido Blanco T; Ferrón Vidán F; Lorenzo González A; Bugallo Paz L
    An Med Interna; 1989 Apr; 6(4):207-8. PubMed ID: 2485076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of amylase in common epithelial tumors of the ovary.
    Ueda G; Yamasaki M; Inoue M; Tanaka Y; Abe Y; Ogawa M
    Int J Gynecol Pathol; 1985; 4(3):240-4. PubMed ID: 2414239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylase from human serous ovarian tumors: purification and characterization.
    Zakowski JJ; Gregory MR; Bruns DE
    Clin Chem; 1984 Jan; 30(1):62-8. PubMed ID: 6197207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic tumour markers in ovarian cancer: a multiparametric study.
    Bose CK; Mukherjea M
    Cancer Lett; 1994 Feb; 77(1):39-43. PubMed ID: 7512886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.